wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38823727-30F04630-6057-4C89-A983-978C7AECBA06
Q38823727-30F04630-6057-4C89-A983-978C7AECBA06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38823727-30F04630-6057-4C89-A983-978C7AECBA06
Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell Death.
P2860
Q38823727-30F04630-6057-4C89-A983-978C7AECBA06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38823727-30F04630-6057-4C89-A983-978C7AECBA06
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f502815a17c84f83cd0c75520cb21d465b09463
P2860
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.